ADAMTS13 Activity and Autoantibodies Subclasses as Recurrency Risk Predictors In Acquired Thrombotic Thrombocytopenic Purpura.

被引：0
|
作者：
Bettoni, Giuseppe [1 ,2 ]
Lotta, Luca A. [1 ,2 ]
Consonni, Dario [3 ]
Motti, Dino F. A. [1 ,2 ]
Palla, Roberta [1 ,2 ]
Valsecchi, Carla [1 ,2 ]
Casoli, Gloria [1 ,2 ]
Rovati, Andrea [4 ]
Pizzuti, Michele [5 ]
Peyvandi, Flora
机构：
[1] Luigi Villa Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Fdn IRCCS Ca Gr, Sci Direct, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Epidemiol, Dipartimento Med Prevent, Milan, Italy
[4] Osped Lodi, Dept Hematol, Lodi, Italy
[5] Osped San Carlo Borromeo Milano, Potenza, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1049 / 1049
页数：1
相关论文
共 50 条
  • [31] Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
    Thomas, Mari R.
    de Groot, Rens
    Scully, Marie A.
    Crawley, James T. B.
    EBIOMEDICINE, 2015, 2 (08): : 942 - 952
  • [32] Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura
    Froehlich-Zahnd, Rahel
    George, James N.
    Vesely, Sara K.
    Terrell, Deirdra R.
    Aboulfatova, Khatira
    Dong, Jing-Fei
    Luken, Brenda M.
    Voorberg, Jan
    Budde, Ulrich
    Sulzer, Irmela
    Laemmle, Bernhard
    Hovinga, Johanna A. Kremer
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (02): : 297 - 303
  • [33] Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats
    Tersteeg, C.
    Schiviz, A.
    Plaimauer, B.
    De Meyer, S. F.
    Scheiflinger, F.
    Vanhoorelbeke, K.
    Rottensteiner, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 152 - 152
  • [34] Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura - Reply
    Kelton, JG
    TRANSFUSION, 2002, 42 (11) : 1524 - 1525
  • [35] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Bendapudi, Pavan K.
    Foy, Brody H.
    Mueller, Sarah B.
    Liu, Jun
    Feingold, Louis M.
    Burke, Kristen E.
    Cruz, Wendy
    Chen, Maria Y.
    Lau, Emily S.
    Goldberg, Rachel L.
    Tatake, Ishan
    Wilkinson, Shelby C.
    Carney, Brian J.
    Stone, James R.
    Park, Doyun
    Avelino, Alzira R.
    Hassan, Sajjad
    Andrzejewski, Chester
    Ruby, Kristen N.
    Friedman, Kenneth D.
    Brunker, Patricia A. R.
    Leaf, Rebecca K.
    Higgins, John
    Dzik, Walter H.
    Stefely, Jonathan A.
    Makar, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (18): : 1690 - 1698
  • [36] Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
    Wendt, Ralph
    Voelker, Linus A.
    Brinkkoetter, Paul T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 382 - 384
  • [37] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Lorenz, Judith
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (05): : 410 - 411
  • [38] Thrombotic Thrombocytopenic Purpura: Relationship of Infection and ADAMTS13
    Watanaboonyongcharoen, P.
    Brecher, M. E.
    Schultz, E. F.
    Hay, S. N.
    Park, Y. A.
    TRANSFUSION, 2012, 52 : 126A - 127A
  • [39] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Asmis, Lars M. M.
    Serra, Andreas
    Krafft, Alexander
    Licht, Abraham
    Leisinger, Elke
    Henschkowski-Serra, Jana
    Ganter, Michael T. T.
    Hauptmann, Steffen
    Tinguely, Marianne
    Hovinga, Johanna A. Kremer A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25): : 2356 - 2361
  • [40] Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura
    Cataland, Spero R.
    Wu, Haifeng M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 437 - 444
12345